PharmaSeed Capital

Read More "Working with the right scientific partners can make a meaningful difference during critical stages of development. It has been a pleasure collaborating with Pharmaseed on our pilot toxicology studies. Their team brought strong scientific expertise, professionalism, flexibility, and a collaborative mindset throughout the process. We especially appreciate the support and guidance of Dr. Ronit Mesilati Stahy, whose thoughtful approach ensured efficient execution at this important stage of development."

Read More "Pharmaseed provided us high quality execution of very complex animal models that were previously unestablished for auto-immune disease, that assessed the safety and activity of our preclinical candidate. The flow of materials, data and scientific communication were maintained even through the challenges of COVID-19 pandemic in 2021"

Read More “Heading Gamida Cell’s R&D I have been working with the Pharmaseed team for 12 years on more than 50 nonclinical, pharmacology, biodistribution and toxicology studies. Pharmaseed team are highly professional while being accommodating and very supportive. They have a very broad knowledge and experience with animal modeling for cell-based therapies. In the last 5 years, they successfully conducted multiple IND-enabling toxicology studies to support the development of our cellular immunotherapy products, including NK and CART cells.”

Read More “I have worked with the Pharmaseed team for 12 years on more than 50 nonclinical, pharmacology, biodistribution and toxicology studies. Pharmaseed team are highly professional while being accommodating and very supportive. They have a very broad knowledge and experience with animal modeling for cell-based therapies. In the last 5 years, they successfully conducted multiple IND-enabling toxicology studies to support the development of our cellular immunotherapy products, including NK and CART cells.”

Read More “Pharmaseed’s team accompanied us through all steps of the different projects, from study design to final reporting, and shared its valuable input and experience to address the challenges that surfaced during the work. The highly qualified and professional team was very involved, demonstrated deep understanding of our projects and showed a sincere desire to help and move our projects forward. As a multi-project, clinical stage company, which works with several preclinical CROs globally, we at Gamida Cell would like to underpin the overall quality, reliability and flexibility we experienced working with Pharmaseed. I therefore strongly recommend their services”